letterTop 1% cited

Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

Journal of Clinical Oncology · 2004 · Vol. 22(16) · pp. 3432–3433

Acute Myeloid Leukemia Research Retinoids in leukemia and cellular processes Chronic Myeloid Leukemia TreatmentsMedicineStandardizationMyeloid leukemiaIntensive care medicineClinical trialOncologyInternal medicine

MeSH terms

Acute DiseaseClinical Trials as TopicHumansInternational CooperationLeukemia, MyeloidReference ValuesTreatment OutcomePractice Guidelines as TopicDisease ProgressionEndpoint Determination

Citations

2,141

FWCI

22.66

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia

Science Translational Medicine · 2016 · 896 citations

Acute Myeloid Leukemia: A Concise Review

Journal of Clinical Medicine · 2016 · 345 citations

Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia

Science Translational Medicine · 2014 · 2,472 citations

Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

Journal of Clinical Oncology · 2004 · 2,141 citations

Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia

Blood · 2017 · 1,447 citations

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

Blood · 2009 · 3,383 citations

Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia

Blood · 2006 · 1,576 citations

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

The Lancet Oncology · 2009 · 2,624 citations

References

The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial

Blood · 1998 · 2,634 citations

A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk

The Annals of Statistics · 1988 · 4,934 citations

Proposals for the Classification of the Acute Leukaemias F<scp>rench</scp>‐A<scp>merican</scp>‐B<scp>ritish</scp> (FAB) C<scp>o‐operative</scp> G<scp>roup</scp>

British Journal of Haematology · 1976 · 5,589 citations

The World Health Organization (WHO) classification of the myeloid neoplasms

Blood · 2002 · 2,174 citations

World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997

Journal of Clinical Oncology · 1999 · 3,285 citations

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis

Blood · 2002 · 1,723 citations

Journal of Clinical Oncology · 2003 · 2,650 citations

Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML‐MO)

British Journal of Haematology · 1991 · 667 citations

Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.